Prometic Life Sciences Inc. (QX) Stock Price - PFSCF

Best deals to access real time data!
SMALL CAP BASIC
Monthly Subscription
for only
$29.03
SMALL CAP PRO
Monthly Subscription
for only
$43.59
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$30.00
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Prometic Life Sciences Inc. (QX) PFSCF Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  -0.04 -2.56% 1.52 1.58 1.52 1.58 1.56 10:47:39
Bid Price Ask Price Spread Spread % News
1.50 1.53 0.03 1.96% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
5.00 22,200.00 $ 1.52 $ 33.8k 61.18k - - -
Last Trade Time Type Quantity Stock Price Currency
10:44:16 1,000.00 $1.52 USD

Prometic Life Sciences Inc. (QX) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 942.77M 604.34M $ -50.96M - - 465.04M
Short Interest Short % of Out Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
20.51M 3.39% $ - 0.00% - -

more financials information »

Prometic Life Sciences Inc. (QX) News


Historical PFSCF Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week1.8151.841.520.000025k168k75k-0.30-16.25%
1 Month2.032.171.520.00004k454k106k-0.51-25.12%
3 Months2.18172.461.520.00001000454k62k-0.66-30.33%
6 Months2.40952.461.520.00000454k44k-0.89-36.92%
1 Year2.272.77391.39650.00000515k48k-0.75-33.04%
3 Years0.7752.77390.7740.00000541k37k0.7596.13%
5 Years0.134816.500.1070.00000993k40k1.391,027.60%

Prometic Life Sciences Inc. (QX) Description

ProMetic Life Sciences Inc. (www.prometic.com) is an established biopharmaceutical company with widely recognized expertise in bioseparations, plasmaderived therapeutics and small-molecule drug development. ProMetic offers its innovative technologies for large-scale purification of biologics, drug development, proteomics and the elimination of pathogens to a growing base of industry leaders and uses its own affinity technology that provides for highly efficient extraction and purification of therapeutic proteins from human plasma in order to develop and commercialize plasma-derived therapeutics. ProMetic is also active in developing its own novel small-molecule therapeutic products targeting unmet medical needs in the fields of fibrosis, anemia, neutropenia, cancer and autoimmune diseases/inflammation as well as certain nephropathies. Headquartered in Laval (Canada), ProMetic has R&D facilities in the United Kingdom, the U.S. and Canada, manufacturing facilities in the United Kingdom and Canada and business development activities in the U.S., Europe and Asia. ProMetic's Common Shares trade on the Toronto Stock Exchange under the symbol "PLI" and the OTCQX International under the symbol "PFSCF".


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.